Data Providers · Datavant
ran a 36-week Phase IV study (175 patients, 40 sites) using trial tokenization to link to real-world data, extending effectiveness/safety analysis of a new focal seizure treatment
The customer is anonymised in Datavant’s own case study — not withheld by us.
Datavant is the tokenization and linkage infrastructure behind most of the US real-world-data ecosystem — it de-identifies and connects patient records across health-data partners without exposing PII.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Source
Published by Datavant on its own site — read the original case study on datavant.com ↗
More like this
Related use cases
- 01built a model (with Datavant matching/linking) to identify hereditary ATTR amyloidosis patients, identifying 60+ new cases
- 02used Datavant's identity resolution technology to narrow duplicate patient counts by 96 million (22%), producing a higher-quality, more comprehensive real-world dataset
- 03peer-reviewed studies using patient-level health data connected by Datavant technology to study intervention/policy effects on outcomes
- 04partnered with Datavant on a flexible, scalable medical coding model to overcome staffing challenges and strengthen compliance
- 05accessed curated AAO IRIS Registry data to understand disease burden, clinical outcomes, comorbidities, and cost/utilization for rare eye disease patients
- 06used Datavant Switchboard to connect specialty pharmacy and patient-hub data to real-world data, addressing infusion-therapy treatment discontinuation and improving patient adherence